Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity

Journal of Cellular Biochemistry

Volumn 98, Issue 5, 2006, Pages 1284-1295

  Kim, Young Ho ^a   Lee, Yong J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Caspase; Cisplatin; Synergistic cytotoxicity; TRAIL

Indexed keywords

ALANINE; ASPARTIC ACID; CASPASE; CISPLATIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CELL INTERACTION; CELL PROTECTION; COMPLEX FORMATION; CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOLID TUMOR; SQUAMOUS CELL CARCINOMA;

AMINO ACID SEQUENCE; APOPTOSIS REGULATORY PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MUTATION; POLY(ADP-RIBOSE) POLYMERASES; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33746428587     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20844     Document Type: Article

References (50)

1. Ashkenazi A, Dixit VM. 1998. Death receptors: Signaling and modulation. Science 281:1305-1308.
2. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J. 2000. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2:241-243.
3. Bulmer JT, Zacal NJ, Rainbow AJ. 2005. Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment. Cancer Chemother Phamacol 56:189-198.
4. Catimel G. 1996. Head and neck cancer: Guidelines for chemotherapy. Drugs 51:73-88.
5. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL, Ross BD, Rehemtulla A. 2000. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci 97:1754-1759.
6. Cohen GM. 1997. Caspases: The executioners of apoptosis. Biochem J 326:1-16.
7. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165-1170.
8. Gazitt Y, Shaughnessy P, Montgomery W. 1999. Apoptosis-induced by TRAIL and TNF-α in human mutiple myeloma cells is not blocked by Bcl-2. Cytokine 11:1010-1019.
9. Goltsev YV, Kovalenko AV, Arnold E, Varfolomeev EE, Brodianskii VM, Wallach D. 1997. CASH, a novel caspase homologue with death effector domains. J Biol Chem 272:19641-19644.
10. Gong B, Almasan A. 2000. Apo2 ligand/TNF-regulated apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Cancer Res 60:5754-5760.
11. Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 161:2833-2840.
12. Gura T. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277:768.
13. Han DK, Chaudhary PM, Wright ME, Friedman C, Trask BJ, Riedel RT, Baskin DG, Schwartz SM, Hood L. 1997. MRIT, a novel death-effector domain-containing protein, interacts with caspases and Bclx1 and initiates cell death. Proc Natl Acad Sci 94:11333-11338.
14. Hardy S, Kitamura M, Harris-Stansil T, Dai Y, Phipps ML. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71:1824-1849.
15. Hsieh MH, Nguyen HT. 2005. Molecular mechanism of apoptosis induced by mechanical forces. Int Rev Cytol 245:45-90.
16. Inohara N, Koseki T, Hu Y, Chen S, Nunez G. 1997. CLARP, a death effector domain-containing protein interacts with caspase-8 and regulates apoptosis. Proc Natl Acad Sci 94:10717-10722.
17. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195.
18. Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. 1999. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59:734-741.
19. Kim JH, Ajaz M, Lokshin A, Lee YJ. 2003. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis. Clin Cancer Res 9:33134-33141.
20. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A. 2000. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611-620.
21. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J Biol Chem 276:20633-20640.
22. Kuang AA, Diehl G, Zhang J, Winoto A. 2000. FADD is required for DR4- and DR5-mediated apoptosis: Lack of TRAIL-induced apoptosis in FADD-deficient mouse embryonic fibroblasts. J Biol Chem 275:25065-25068.
23. Kuwahara D, Tsutsumi K, Kobayashi T, Hasunuma T, Nishioka K. 2000. Caspase-9 regulates cisplatin-induced apoptosis in human head and neck squamous cell carcinoma cells. Cancer Lett 148:65-71.
24. Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT. 2001. Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res 61:1645-1651.
25. Laemmli UK. 1970. Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature 227:680-685.
26. Lee YJ, Chen JC, Amoscato AA, Bennouna J, Spitz DR, Suntharalingam M, Rhee JG. 2001a. Protective role of Bcl-2 in metabolic oxidative stress-induced cell death. J Cell Sci 114:677-684.
27. Lee YJ, Lee KH, Kim HR, Jessup JM, Seol DW, Kim TH, Billiar TR, Song YK. 2001b. Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells. Oncogene 20:1476-1485.
28. Li H, Zhu H, Xu C, Yuan J. 1998. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501.
29. Li F, Meng L, Zhou J, Xing H, Wang S, Xu G, Zhu H, Wang B, Chen G, Lu YP, Ma D. 2005. Reversing chemoresistance in cisplatin-resistant human ovarian cancer cells: A role of c-Jun NH2-terminal kinase 1. Biochem Biophys Res Commun 335:1070-1077.
30. Liu W, Bodle E, Chen JY, Gao M, Rosen GD, Broaddus VC. 2001. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. Am J Respir Cell Mol Biol 25:111-118.
31. Mac-Farlane DF, Pustelny BL, Goldberg LH. 1997. Mohs surgery for nonagenerians. Dermatol Surg 23:848-849.
32. Mandic A, Viktorsson K, Strandberg L, Heiden T, Hansson J, Linder S, Shoshan MC. 2002. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: Two separate pathways in cisplatin-induced apoptosis. Mol Cell Biol 22:3003-3013.
33. Mandic A, Hansson J, Linder S, Shoshan MC. 2003. Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol Chem 278:9100-9106.
34. Mariani SM, Matiba B, Armandola EA, Krammer PH. 1997. Interleukin 1 beta-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J Cell Biol 137:221-229.
35. Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A. 1997. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7:1003-1006.
36. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ. 2000. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60:847-853.
37. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818.
38. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A. 1996. Induction of apoptosis by Apo2 ligand, a new member of the tumor necrosis factor receptor family. J Biol Chem 271:12687-12690.
39. Scaffidi C, Schmitz I, Krammer PH, Peter ME. 1999. The role of cFLIP in modulation of CD95-induced apoptosis. J Biol Chem 274:1541-1548.
40. Schendel SL, Azimov R, Pawlowski K, Godzik A, Kagan BL, Reed JC. 1999. Ion channel activity of the BH3 only Bcl-2 family member, BID. J Biol Chem 274:21932-21936.
41. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Jr., Fornace AJ, el-Deiry WS. 1998. p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor α. Cancer Res 58:1593-1598.
42. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821.
43. Shu HB, Halpin DR, Goeddel DV. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6: 751-763.
44. Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ. 1999. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J Cell Biol 144:281-292.
45. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J, Krammer PH, Walczak H. 2000. FADD/MORT1 and caspase-8 are recruited to TRAIL receptor 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 12:599-609.
46. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM. 1999. Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053-5060.
47. Tannock IF, Browman G. 1986. Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J Clin Oncol 4:1121-1126.
48. Tschopp J, Irmler M, Thome M. 1998. Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10:552-558.
49. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT. 1997. TRAIL-R2: A novel apoptosis-mediating receptor for TRAIL. EMBO J 16:5386-5397.
50. Walczak H, Bouchon A, Stahl H, Krammer PH. 2000. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2 or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Cancer Res 60:3051-3057.